The Case for Biennial Retinopathy Screening in Children and Adolescents
Response to Amin
- Ann M. Maguire, MB, BAO, BCH1,
- Albert K.F. Chan, MAPPSTAT1,
- Janine M. Cusumano1,
- Stephen J. Hing, MBBS1,
- Maria E. Craig, PHD123,
- Martin Silink, MD12,
- Neville J. Howard, MBBS1 and
- Kim C. Donaghue, PHD12
- 1Institute of Endocrinology and Diabetes, The Children’s Hospital at Westmead, Sydney, Australia
- 2Department of Paediatrics and Child Health, University of Sydney, Sydney, Australia
- 3School of Women’s and Children’s Health, University of New South Wales, Sydney, Australia
- Address correspondence to Dr. Ann Maguire, Institute of Endocrinology and Diabetes, The Children’s Hospital at Westmead, Locked Bag 4001, Sydney, NSW 2145, Australia. E-mail: annm4{at}chw.edu.au
In response to the letter from Amin (1), we provide further details on the risk factors for progression and regression of retinopathy in our natural history study (2). Of 136 patients with retinopathy at baseline, 72 progressed or persisted compared with 50 patients (37%) who regressed to no retinopathy and 14 who regressed to a lower grade of retinopathy after …
